KSPI · DEEP VALUE BRIEFING

Joint Stock Company Kaspi.kz (KSPI)

published May 11, 2026 · price now $94.25 · market cap $17.9B

WATCH · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

KSPI is interesting, not yet high-certainty. The bull case is strong on valuation and apparent franchise quality: about 7.3x P/E, 43% ROE, 71% gross margin, nearly 60% revenue growth, and a recent EPS/revenue beat. But the core Buffett-style risk issue remains unresolved: revenue is compounding far faster than profit (~59.8% revenue growth vs ~3.2% net income growth), which is exactly the kind of mismatch that can signal weaker earnings quality in a payments/lending hybrid. For a long-term investor focused on avoiding permanent impairment, that matters more than short-term momentum or headline cheapness.

My conclusion: WATCH. KSPI may be mispriced, but it does not yet offer the level of earnings durability, balance-sheet clarity, and business predictability required for full conviction. Best course: keep it on a short leash, consider only modest exposure if your process allows, and demand proof that profit quality is catching up to revenue growth.

Key Arguments from the Analysts

Risky Analyst’s strongest points

  • KSPI screens as unusually cheap for its visible quality:
  • P/E 7.31
  • ROE 43.1%
  • Gross margin 71.2%
  • Revenue growth 59.8%
  • Recent operating momentum was strong:
  • EPS $2.77 vs $2.41 consensus
  • Revenue $2.257B vs $2.120B consensus
  • If KSPI is truly a dominant local ecosystem across payments, marketplace, and finance, then the market may be over-discounting country/financial complexity.
  • A rerating from ~7x earnings to even a more modest multiple could create meaningful upside before considering ongoing growth.

Safe Analyst’s strongest points

  • The central warning is the large divergence between top-line growth and bottom-line growth:
  • Revenue +59.8%
  • Net income +3.2%
  • EPS +6.95%
  • In a business with financial exposure, this divergence can indicate:
  • lower-quality incremental growth,
  • rising credit costs,
  • reserve pressure,
  • funding intensity,
  • or less durable returns than headline metrics suggest.
  • A low multiple is not automatically a margin of safety if the “E” in P/E is not dependable.
  • Country, regulatory, and funding risks are not one-time facts; they can remain or intensify.

Neutral Analyst’s strongest points

  • Both sides are partly right:
  • the business looks too good superficially to dismiss,
  • but the unresolved earnings-quality issue is too important to ignore.
  • The practical compromise is not “full conviction” and not “ignore it,” but measured exposure with strict monitoring.
  • Position sizing can bridge uncertainty better than false precision.

Rationale

Under Buffett’s framework, the key question is not whether KSPI is volatile or unloved. It is whether the business faces a meaningful chance of permanent impairment through weak underwriting, regulatory disruption, funding strain, or structurally lower earnings quality than reported metrics imply.

The bullish evidence is real. Businesses do not usually show 43% ROE, 71% gross margin, and strong revenue growth by accident. The latest quarter also weakens any simplistic “something is broken” argument. On the surface, this does resemble the kind of fear-driven discount that can create attractive long-term returns.

But the strongest counterpoint is stronger still: in a hybrid commerce/payments/finance business, profit conversion matters more than optical growth. A business growing revenue nearly 60% while barely growing net income is not yet proving the kind of predictable owner earnings that Buffett would demand for a “wonderful business” purchased with confidence. The market may indeed be wrong — but it may also be correctly signaling skepticism toward the durability of those earnings.

That distinction is critical. Many investor mistakes come from confusing:

  • high historical returns with durable future economics,
  • cheapness with margin of safety,
  • and story strength with earnings certainty.

The lesson to apply here is simple: do not let flattering summary metrics overpower unresolved questions about earnings quality. In finance-linked businesses especially, headline profitability can look excellent right before a cycle or regulatory shift exposes weaker foundations. That does not mean KSPI is such a case — only that we do not yet have enough evidence to dismiss the risk.

Refined Investor Plan

Your original plan already lands in the right place: interested, but demanding. I would refine it slightly:

  • Keep the base stance at WATCH.
  • If your framework allows partial entries, treat this as a small, probationary position only, not a full Buffett-style commitment.
  • Do not upgrade to conviction based only on low valuation, one earnings beat, or technical strength.

What must improve before an upgrade

  1. Profit growth must begin to better track revenue growth
  • If revenue keeps compounding while profit lags badly, the quality case weakens.
  1. Credit quality and reserve behavior must remain sound
  • Watch delinquencies, charge-offs, reserve builds, underwriting trends.
  1. Segment mix should become clearer
  • More profit contribution from payments/marketplace vs lending would improve predictability.
  1. Balance-sheet and funding resilience must be visible
  • Capital ratios, funding mix, liquidity, and management risk controls matter.
  1. Regulatory and country risks must remain manageable
  • Especially if they affect lending economics, capital rules, or platform dominance.

What would justify an upgrade to ADVOCATE

  • Sustained profit growth catching up materially,
  • stable credit performance through growth,
  • clearer evidence that ecosystem economics are broad-based rather than credit-driven,
  • and no meaningful deterioration in funding or regulation.

What would push it toward AVOID

  • Continued weak profit conversion,
  • worsening credit metrics,
  • rising reserve/funding stress,
  • or regulatory changes that impair economics or the moat.

Final Stance

WATCH

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 4, 2026; the market price was $94.25. Values are estimates, not predictions.

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $819.60 / $863.91 / $1519.87 (conservative / base / optimistic)

Starting Damodaran FCFF$2.1B
Growth: conservative / base / optimistic (2021–2025)25.0% / 25.0% / 35.0%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt6.39%
Equity weight100%
WACC (discount rate)9.43%
Target operating margin (base)53.4%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding190M

This briefing is from May 11, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

生成最新简报 →Watch the video briefingGet the iPhone app

周一价值信

每周一封:杰出价值投资者买了什么、卖了什么,以及我们的看法。

请每周给我发送一封 DeepValues 周一价值信。我可以随时退订。仅供参考,不构成投资建议。 隐私政策